“MEASURED - REAL VALUES OF INTRAOCULAR TENSION, 24 H AFTER THE APPLICATION OF BROLUCIZUMAB INTRAVITREAL INJECTION IN PATIENTS WITH WAMD”. MEDIS – International Journal of Medical Sciences and Research, vol. 3, no. 3, Sept. 2024, pp. 23-26, https://doi.org/10.35120/medisij030323h.